My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Archivos Españoles de Urología (Ed. impresa)
Print version ISSN 0004-0614
Abstract
ARRATIA-MAQUEO, Jorge A.; CORTES-GONZALEZ, Jeff R.; GARZA-CORTES, Roberto and GOMEZ-GUERRA, Lauro S.. Prospective study of prostate cancer's detection rate at our hospital in Northeast Mexican patients with PSA values between 2.6 y 4 ng/ml. Arch. Esp. Urol. [online]. 2010, vol.63, n.4, pp.287-290. ISSN 0004-0614.
Objectives: To find the detection rate of prostate cancer (PCa) in our population with PSA values between 2.6 and 4 ng/ml. Methods: We included 33 consecutive patients with a median age of 66 years, that had a Transrectal Ultrasound (TRUS) guided biopsy with PSA between 2.6-4 ng/ml. Patients were divided into 2 groups. Group 1: patients with normal Digital Rectal Examination (DRE) and Group 2: Patients with DRE with asymmetry not definitive of PCa. Exclusion criteria: known history of PCa, intraepithelial neoplasia or Positive DRE. Statistical analysis: Chi square, t-student and Fischer exact test. Results: Twenty eight percent of the patients (9) had positive biopsy for PCa. Fifty six percent (5) were Gleason 6 and 44% (4) Gleason 7 (3+4). Group 1 had 59% (20) and Group 2 41% in. In Group 1 16% (3) had positive biopsy for PCa vs 46% (6) in group 2 (p 0.04) RR 3.07. Conclusions: There are traces that the detection rate in our population could be lower in comparison with what has been reported in the literature. DRE is crucial in the initial evaluation; asymmetry could increase 3 fold the risk of having PCa.
Keywords : Prostatic cancer; PSA; Biopsy.